Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Deschoolmeester, Vanessa ^a   Van Marck, Veerle ^b   Baay, Marc ^a   Weyn, Christine ^c   Vermeulen, Peter ^d   Van Marck, Eric ^b   Lardon, Filip ^a   Fontaine, Veronique ^c   Vermorken, Jan B ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d SINT AUGUSTINUS HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN E7; VIRUS DNA; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS TYPING; AGE; CANCER STAGING; CELL DIFFERENTIATION; CHEMISTRY; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MICROSATELLITE INSTABILITY; MIDDLE AGED; MORTALITY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TIME; UPREGULATION; VIROLOGY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77952923044     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-117     Document Type: Article

References (52)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005, 365:153-165. 10.1016/S0140-6736(05)17706-X, 15639298.
2. Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP, Ruppenthal RD, Alexandre CO. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 2007, 33:569-574. 10.1016/j.ejso.2007.01.014, 17321098.
3. Kirgan D, Manalo P, Hall M, McGregor B. Association of human papillomavirus and colon neoplasms. Arch Surg 1990, 125:862-865.
4. Cheng JY, Meng CL, Chao CF, Gau SD, Lin JC. Human papillomavirus type-related DNA and c-myc oncogene alterations in colon cancer cell lines. Dis Colon Rectum 1991, 34:469-474. 10.1007/BF02049931, 1645245.
5. McGregor B, Byrne P, Kirgan D, Albright J, Manalo P, Hall M. Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg 1993, 166:738-740. 10.1016/S0002-9610(05)80690-7, 8273860.
6. Cheng JY, Sheu LF, Lin JC, Meng CL. Detection of human papillomavirus DNA in colorectal adenomas. Arch Surg 1995, 130:73-76.
7. Cheng JY, Sheu LF, Meng CL, Lee WH, Lin JC. Detection of human papillomavirus DNA in colorectal carcinomas by polymerase chain reaction. Gut 1995, 37:87-90. 10.1136/gut.37.1.87, 1382774, 7672688.
8. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001, 34:87-91.
9. Audeau A, Han HW, Johnston MJ, Whitehead MW, Frizelle FA. Does human papilloma virus have a role in squamous cell carcinoma of the colon and upper rectum?. Eur J Surg Oncol 2002, 28:657-660. 10.1053/ejso.2002.1304, 12359204.
10. Perez L, Abba M, Laguens R, Golijow C. Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis 2005, 7:492-5. 10.1111/j.1463-1318.2005.00774.x, 16108887.
11. Bodaghi S, Yamanegi K, Xiao S, Da Costa M, Palefsky J, Zheng Z. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005, 11:2862-7. 10.1158/1078-0432.CCR-04-1680, 1479314, 15837733.
12. Buyru N, Tezol A, Dalay N. Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 2006, 6:115. 10.1186/1471-2407-6-115, 1481576, 16672071.
13. Palmer JG, Scholefield JH, Coates PJ, Shepherd NA, Jass JR, Crawford LV, Northover JM. Anal cancer and human papillomaviruses. Dis Colon Rectum 1989, 32:1016-1022. 10.1007/BF02553872, 2556252.
14. Beckmann AM, Daling JR, Sherman KJ, Maden C, Miller BA, Coates RJ, Kiviat NB, Myerson D, Weiss NS, Hislop TG. Human papillomavirus infection and anal cancer. Int J Cancer 1989, 43:1042-1049. 10.1002/ijc.2910430615, 2543642.
15. Shah KV, Daniel RW, Simons JW, Vogelstein B. Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 1992, 51:5-7. 10.1002/jso.2930510104, 1325576.
16. Shroyer KR, Kim JG, Manos MM, Greer CE, Pearlman NW, Franklin WA. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg 1992, 127:741-744.
17. Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci 2007, 98:1505-1511. 10.1111/j.1349-7006.2007.00546.x, 17645777.
18. Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 1989, 8:4099-4105. 401588, 2556261.
19. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998, 153:1741-1748. 1866324, 9846965.
20. Krakowczyk L, Strzelczyk JK, Adamek B, Zalewska-Ziob M, Arendt J, Poltorak S, Maciejewski B, Wiczkowski A. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa. Med Sci Monit 2008, 14:BR219-BR225.
21. Reuschenbach M, Waterboer T, Wallin KL, Einenkel J, Dillner J, Hamsikova E, Eschenbach D, Zimmer H, Heilig B, Kopitz J, Pawlita M, Doeberitz MK, Wentzensen N. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer 2008, 123:2626-2631. 10.1002/ijc.23837, 18785210.
22. Sahebali S, Depuydt CE, Segers K, Moeneclaey LM, Vereecken AJ, Van ME, Bogers JJ. P16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer 2004, 108:871-876. 10.1002/ijc.11589, 14712490.
23. Cunningham MP, Essapen S, Thomas H, Green M, Lovell DP, Topham C, Marks C, Modjtahedi H. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients. Int J Oncol 2006, 28:329-335.
24. Walts AE, Lechago J, Bose S. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Am J Surg Pathol 2006, 30:795-801. 10.1097/01.pas.0000208283.14044.a9, 16819320.
25. Kong CS, Welton ML, Longacre TA. Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum. Am J Surg Pathol 2007, 31:919-925. 10.1097/01.pas.0000213441.86030.fc, 17527081.
26. Deschoolmeester V, Van Damme N, Baay M, Claes K, Van Marck E, Baert FJ, Wuyts W, Cabooter M, Weyler J, Vermeulen P, Lardon F, Vermorken JB, Peeters M. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population. Eur J Cancer 2008, 44:2288-2295. 10.1016/j.ejca.2008.06.043, 18707864.
27. Deschoolmeester V, Baay M, Wuyts W, Van Marck E, Pelckmans P, Lardon F, Vermorken JB. Comparison of three commonly used PCR-based techniques to analyze MSI status in sporadic colorectal cancer. J Clin Lab Anal 2006, 20:52-61. 10.1002/jcla.20097, 16538640.
28. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988, 239:487-91. 10.1126/science.2448875, 2448875.
29. Baay MFD, Quint WGV, Koudstaal J, Hollema H, Duk JM, Burger MPM, Stolz E, Herbrink P. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996, 34:745-747. 228883, 8904451.
30. Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B, Quint W. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998, 153:1731-9. 1866345, 9846964.
31. Kleter B, van Doorn LJ, Schrauwen L, Molijn A, Sastrowijoto S, ter Schegget J, Lindeman J, ter Harmsel B, Burger M, Quint W. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999, 37:2508-2517. 85270, 10405393.
32. Fontaine V, Mascaux C, Weyn C, Bernis A, Celio N, Lefevre P, Kaufman L, Garbar C. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol 2007, 45:928-934. 10.1128/JCM.02098-06, 1829119, 17229855.
33. Quint WGV, Scholte G, van Doorn LJ, Kleter B, Smits PHM, Lindeman J. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10PCR and HPV genotyping. J Pathol 2001, 194:51-58. 10.1002/path.855, 11329141.
34. Deschoolmeester V, Baay M, Wuyts W, Van Marck E, Van Damme N, Vermeulen P, Lukaszuk K, Lardon F, Vermorken JB. Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers. J Mol Diagn 2008, 10:154-159. 10.2353/jmoldx.2008.070087, 2259470, 18258928.
35. Mouron SA, Abba MC, Guerci A, Gomez MA, Dulout FN, Golijow CD. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions. Mutat Res 2000, 469:127-134.
36. Prokopakis P, Sourvinos G, Koumantaki Y, Koumantakis E, Spandidos DA. K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix. Oncol Rep 2002, 9:129-133.
37. Pochylski T, Kwasniewska A. Absence of point mutation in codons 12 and 13 of K-RAS oncogene in HPV-associated high grade dysplasia and squamous cell cervical carcinoma. Eur J Obstet Gynecol Reprod Biol 2003, 111:68-73. 10.1016/S0301-2115(03)00205-7, 14557015.
38. Dokianakis DN, Papaefthimiou M, Tsiveleka A, Spandidos DA. High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears. Oncol Rep 1999, 6:1327-1331.
39. Cheng JY, Meng CL, Chao CF, Gau SD, Lin JC. Human papillomavirus 16 DNA in NIH3T3 cells transformed by colonic cancer cellular DNA. Gut 1993, 34:1710-1713. 10.1136/gut.34.12.1710, 1374468, 8282259.
40. Yu HG, Shun LB, Luo HS, Huang H, Yu BP, Yu JP, Meier JJ, Schrader H, Bastian A, Schmitz F, Schmidt WE. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection. Int J Colorectal Dis 2002, 17:396-401. 10.1007/s00384-002-0404-9, 12355215.
41. Estes JM, Kirby TO, Huh WK. Autoclave sterilization of instruments used on women with cervical neoplasia is an effective method of eradicating residual human papillomavirus DNA: a polymerase chain reaction-based evaluation. J Low Genit Tract Dis 2007, 11:12-17. 10.1097/01.lgt.0000229565.19364.cc, 17194945.
42. Anonymous Colonoscopes may spread HCV and HPV. AIDS Patient Care STDS 2003, 17:257-258. Anonymous.
43. Ferenczy A, Bergeron C, Richart RM. Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 1989, 74:950-954.
44. Szentirmay Z, Polus K, Tamas L, Szentkuti G, Kurcsics J, Csernak E, Toth E, Kasler M. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations. Cancer Metastasis Rev 2005, 24:19-34. 10.1007/s10555-005-5045-3, 15785870.
45. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009, 27:1992-1998. 10.1200/JCO.2008.20.2853, 19289615.
46. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26:612-619. 10.1200/JCO.2007.14.1713, 18235120.
47. Schneider-Stock R, Boltze C, Peters B, Hopfner T, Meyer F, Lippert H, Roessner A. Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas. Int J Oncol 2003, 23:1009-1013.
48. Lam AK, Ong K, Giv MJ, Ho YH. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008, 40:580-585. 10.1080/00313020802320713, 18752124.
49. Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma. World J Gastroenterol 2003, 9:2202-2206.
50. Cui X, Shirai Y, Wakai T, Yokoyama N, Hirano S, Hatakeyama K. Aberrant expression of pRb and p16(INK4), alone or in combination, indicates poor outcome after resection in patients with colorectal carcinoma. Hum Pathol 2004, 35:1189-1195. 10.1016/j.humpath.2004.06.010, 15492985.
51. Suter CM, Norrie M, Ku SL, Cheong KF, Tomlinson I, Ward RL. CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer 2003, 88:413-419. 10.1038/sj.bjc.6600699, 2747532, 12569385.
52. Tada T, Watanabe T, Kazama S, Kanazawa T, Hata K, Komuro Y, Nagawa H. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers. Hepatogastroenterology 2003, 50:1756-1760.